Meridian Bioscience, Inc. Sustainability Profile
Meridian Bioscience, Inc., a leading player in the life sciences industry, is headquartered in the United States. Founded in 1976, the company has established itself as a key provider of diagnostic products and life science reagents, primarily focusing on infectious disease testing and molecular diagnostics. With a strong presence in North America and Europe, Meridian Bioscience is renowned for its innovative solutions, including its proprietary immunoassay and molecular technologies. The company’s commitment to quality and accuracy has positioned it as a trusted partner in the healthcare sector. Notable achievements include significant advancements in rapid testing methodologies, which have enhanced patient care and diagnostic efficiency. Meridian Bioscience continues to drive progress in the industry, making it a pivotal entity in the realm of bioscience.
DitchCarbon Score
How does Meridian Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Meridian Bioscience, Inc.'s score of 41 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Meridian Bioscience, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is a current subsidiary of SD Biosensor, Inc., which may influence its climate commitments and performance metrics. While there are no documented reduction targets or climate pledges from Meridian Bioscience, the broader context of its parent company, SD Biosensor, Inc., may provide insights into potential sustainability initiatives. However, specific details regarding emissions reduction strategies or targets are not available at this time. As a subsidiary, Meridian Bioscience may align with the climate commitments and strategies of SD Biosensor, Inc., but without explicit data or targets, the company's individual climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,335,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 11,402,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Meridian Bioscience, Inc.'s Industry?
How Carbon Intensive is Meridian Bioscience, Inc.'s Location?
Meridian Bioscience, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Meridian Bioscience, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
